InsiderTrades

Form 4 for CGNX COGNEX CORP

Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001194210-23-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-21 2023-02-16 CGNX Todgham Paul SVP, CFO M - OptEx $0.00 +2,486 13.6K +22% $0
D 2023-02-21 2023-02-16 CGNX Todgham Paul SVP, CFO F - Tax $55.31 -818 12.8K -6% -$45.2K
D 2023-02-21 2023-02-16 CGNX Todgham Paul SVP, CFO M - OptEx $0.00 -2,486 4,144 -37% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-16 M A 2,486 $0.00 13,570 D — —
2 Common Common Stock 2023-02-16 F D 818 $55.31 12,752 D — —
3 Derivative Restricted Stock Unit 2023-02-16 M D 2,486 $0.00 4,144 D $0.00 · 2022-02-16 to 2024-02-16 2,486 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. (F3) The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 16, 2021), respectively.